Login / Signup
Zanubrutinib plus cytarabine in patients with refractory/relapsed primary central nervous system lymphoma.
Zhiguang Lin
Jingjing Ma
Yan Ma
Qing Li
Hui Kang
Mengxue Zhang
Bobin Chen
Published in:
Acta haematologica (2024)
Zanubrutinib and cytarabine showed efficacy in r/r PCNSL with an acceptable safety profile.
Keyphrases
</>
acute myeloid leukemia
diffuse large b cell lymphoma
high dose
cerebrospinal fluid
low dose